PPPM (Predictive, Preventive and Personalized Medicine) as a New Model of the National and International Healthcare Services and Thus a Promising Strategy to Prevent a Disease: From Basics to Practice
- 1 I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- 2 European Association for Predictive, Preventive and Personalized Medicine (EPMA), Brussels, EU Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany
- 3 I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- 4 I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- 5 International Society for Personalized Medicine (ISPM), Tokyo, Japan
- 6 Department of Medicine, Genetics and Comparative Pathology, University of Alabama at Birmingham (UAB), Birmingham, USA
- 7 I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- 8 Université du Luxembourg and IBBL (Integrated BioBank of Luxembourg), Luxembourg, EU
- 9 National Research University “Higher School of Economics”, Moscow, Russia
- 10 Institute of Population Health and Health Economics, University of Manchester, Manchester, UK
- 11 I.M. Sechenov First Moscow State Medical University, Moscow, Russia A.I. Evdokimov Moscow State Medical & Dental University, Moscow, Russia United Cultural Convention (UCC), Cambridge, UK
Abstract
Nowadays the system of public health is constructed in such a manner so that its main objective is the recovery of an already sick person, while prediction and prevention receive little attention. Meanwhile the development of these aspects of medicine can lead to the ability to control morbidity among the population, to identify chronic and genetic diseases in the early stages of develop ment, and thus to prevent their further progression. This will reduce traditionally high costs of sick people treatment and the number of disabled population, and improve the quality and duration of life. The elaboration of new fields of science that are working on the study and interpretation of data obtained during laboratory and clinical research, creation of new methods for diagnosis, prognosis and treatment, provides an opportunity now to implement a new strategy, called PPPM, and gets promising results, which should lead to further development of an existing medicine.
- Ray, R. (2012) The Future of Medicine. American Journal of Medicine, 125, 236-239. http://www.ncbi.nlm.nih.gov/pubmed/22340917 http://dx.doi.org/10.1016/j.amjmed.2011.06.035
- Gabibov, A.G., Paltsev, M.A. and Suchkov, S.V. (2011) Antibody-Associated Proteolysis in Surveillance of Autoimmune Demyelination: Clinical and Preclinical Issues. Future Neurology, 6, 303-305. http://www.futuremedicine.com/toc/fnl/6/3 http://dx.doi.org/10.2217/fnl.11.17
- Bodrova, T.A., Kostyushev, D.S., Antonova, E.N., Slavin, S., Gnatenko, D.A., Bocharova, M.O., Legg, M., Pozzilli, P., Paltsev, M.A. and Suchkov, S.V. (2012) Introduction into PPPM as a New Paradigm of Public Health Service: An Integrative View. EPMA Journal, 3, 16. http://www.epmajournal.com/content/3/1/16
- Golubnitschaja, O. and Costigliola, V. (2010) Common Origin but Individual Outcomes: Time for New Guidelines in Personalised Healthcare. Personalized Medicine, 7, 561-568. http://www.futuremedicine.com/doi/abs/10.2217/pme.10.42 http://dx.doi.org/10.2217/pme.10.42
- Nair, V.S., Maeda, L.S. and Ioannidis, J.P. (2012) Clinical Outcome Prediction by microRNAs in Human Cancer: A Systematic Review. Journal of the National Cancer Institute, 104, 528-540. http://jnci.oxfordjournals.org/content/early/2012/03/06/jnci.djs027.full http://dx.doi.org/10.1093/jnci/djs027
- Jones, T. and Price, P. (2012) Development and Experimental Medicine Applications of PET in Oncology: A Historical Perspective. Lancet Oncology, 13, e116-e125. http://www.ncbi.nlm.nih.gov/pubmed/22381934 http://dx.doi.org/10.1016/S1470-2045(11)70183-8
- Patel, N.R., McPhail, M.J., Shariff, M.I., Keun, H.C. and Taylor-Robinson, S.D. (2012) Biofluid Metabonomics Using (1)H NMR Spectroscopy: The Road to Biomarker Discovery in Gastroenterology and Hepatology. Expert Review of Gastroenterology and Hepatology, 6, 239-251. http://www.ncbi.nlm.nih.gov/pubmed/22375528 http://dx.doi.org/10.1586/egh.12.1
- Hood, L., Balling, R. and Auffray, C. (2012) Revolutionizing Medicine in the 21st Century through Systems Approaches. Biotechnology Journal, 7, 992-1001. http://www.ncbi.nlm.nih.gov/pubmed/22815171 http://dx.doi.org/10.1002/biot.201100306
- Tran, B., Dancey, J.E., Kamel-Reid, S., McPherson, J.D., Bedard, P.L., Brown, A.M., Zhang, T., Shaw, P., Onetto, N., Stein, L., Hudson, T.J., Neel, B.G. and Siu, L.L. (2012) Cancer Genomics: Technology, Discovery, and Translation. Journal of Clinical Oncology, 30, 647-660. http://www.ncbi.nlm.nih.gov/pubmed/22271477 http://dx.doi.org/10.1200/JCO.2011.39.2316